NCT05135312 Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging Status UNKNOWN Phase PHASE4
NCT05118854 A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation Status RECRUITING Phase PHASE2
NCT05111626 Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05094336 A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05074810 Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05073315 A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT05062759 Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma Status COMPLETED Phase PHASE3
NCT05060016 A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05056246 Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants Status COMPLETED Phase PHASE1
NCT05054725 Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies Status COMPLETED Phase PHASE2
NCT05052801 Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05048784 A Study to Compare the Pharmacokinetics of Two Different Tablets of Sotorasib in Healthy Participants Status COMPLETED Phase PHASE1
NCT05045638 Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin in Healthy Participants Status COMPLETED Phase PHASE1
NCT05032066 A Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis Status TERMINATED Phase PHASE2
NCT05002998 TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study Status COMPLETED Phase PHASE4
NCT04998747 A Study of Subcutaneous (SC) AMG 701 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) Status WITHDRAWN Phase PHASE1
NCT04994717 Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04987333 Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants Status COMPLETED Phase PHASE1
NCT04987320 A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Olpasiran in Chinese Participants With Elevated Serum Lipoprotein(a) Status COMPLETED Phase PHASE1